Ischaemic postconditioning: From bench to bedside

Cardiovascular Journal of Africa

Volumn 19, Issue 6, 2008, Pages 311-320

  Van Vuuren, Derick ^a   Lochner, Amanda ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; BRADYKININ; BRAIN NATRIURETIC PEPTIDE; ISOFLURANE; LACTATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE;

ACUTE HEART INFARCTION; ALGORITHM; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CELL CULTURE; CORONARY ARTERY LIGATION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART INFARCTION SIZE; HEART MUSCLE NECROSIS; HEART PROTECTION; HEART RATE VARIABILITY; HEART VALVE REPLACEMENT; HUMAN; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; ISOLATED HEART; NONHUMAN; POSTCONDITIONING; REPERFUSION; REVIEW;

ALGORITHMS; ANIMALS; CARDIOVASCULAR AGENTS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOGS; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MICE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RABBITS; RATS; SWINE;

EID: 58149505864     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-1504.
2. Mathers CD, Loncar D. Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Med 2006; 3(11): 2011-2030.
3. Jennings RB, Reimer KA. Factors involved in salvaging ischemic myocardium: effect of reperfusion of arterial blood. Circulation 1983; 68(Suppl I): I-25-I-36.
4. Tissier R, Berdeaux A, Ghaleh B, Couvreur N, Krieg T, Cohen MV, Downey JM. Making the heart resistant to infarction: how can we further decrease infarct size? Front Biosci 2008; 13: 284-301.
5. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
6. Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 2003; 83: 1113-1151.
7. Zhao Z-Q, Corvera JS, Halkos ME, Kerendi F, Wang N-P, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285: H579-H588.
8. Vinten-Johansen J, Zhao Z-Q, Zatta AJ, Kin H, Halkos ME, Kerendi F. Postconditioning: A new link in nature's armor against myocardial ischemia-reperfusion injury. Basic Res Cardiol 2005; 100(4): 295-310.
9. Tsang A, Hausenloy DJ, Yellon DM. Myocardial postconditioning: reperfusion injury revisited. Am J Physiol Heart Circ Physiol 2005; 289: H2-H7.
10. Halkos ME, Kerendi F, Corvera JS, Wang N-P, Kin H, Payne CS, et al. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. Ann Thorac Surg 2004; 78: 961-969.
11. Mykytenko J, Kerendi F, Reeves JG, Kin H, Zatta AJ, Jiang R, et al. Long-term inhibition of myocardial infarction by postconditioning during reperfusion. Basic Res Cardiol 2007; 102: 90-100.
12. Couvreur N, Lucats L, Tissier R, Bize A, Berdeaux A, Ghaleh B. Differential effects of postconditioning on myocardial stunning and infarction: a study in conscious dogs and anesthetized rabbits. Am J Physiol Heart Circ Physiol 2006; 291: H1345-H1350.
13. Fujita M, Asanuma H, Hirata A, Wakeno M, Takahama H, Sasaki H, et al. Prolonged transient acidosis during early reperfusion contributes to the cardioprotective effects of postconditioning. Am J Physiol Heart Circ Physiol 2007; 292(4): H2004-H2008.
14. Yang X-M, Proctor JB, Cui L, Krieg T, Downey JM, Cohen MV. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 2004; 44(5): 1103-1110.
15. Downey JM, Cohen MV. We think we see a pattern emerging here. Circulation 2005; 111: 120-121.
16. 2b receptor cascade. Cardiovasc Res 2006; 70: 308-314.
17. Yang X-M, Philipp S, Downey JM, Cohen MV. Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol 2005; 100: 57-63.
18. Darling CE, Jiang R, Maynard M, Whittaker P, Vinten-Johansen J, Przyklenk K. Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. Am J Physiol Heart Circ Physiol 2005; 289: H1618-H1626.
19. Iliodromitis EK, Zoga A, Vrettou A, Andreadou I, Paraskevaidis IA, Kaklamanis L, et al. The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis 2006; 188: 356-362.
20. Chiari PC, Bienengraeber MW, Pagel PS, Krolikowski JG, Kersten JR, Warltier DC. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 2005; 102: 102-109.
21. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation 2005; 111: 194-197.
22. 2A receptor activation [abstract]. Circulation 2006; 114(18 Suppl II): 272.
23. Tsutsumi YM, Yokoyama T, Horikawa Y, Roth DM, Patel HH. Reactive oxygen species trigger ischemic and pharmacological postconditioning: In vivo and in vitro characterization. Life Sci 2007; 81: 1223-1227.
24. Gomez L, Gharib A, Paillard M, Ovize M. Postconditioning requires inactivation of GSK3β upstream of the mPTP in mice [abstract]. J Mol Cell Cardiol 2007; 42: S181-S182.
25. Penna C, Cappello S, Mancardi D, Raimondo S, Rastaldo R, Gattullo D, et al. Post-conditioning reduces infarct size in the isolated rat heart: Role of coronary flow and pressure and the nitric oxide/cGMP pathway. Basic Res Cardiol 2006; 101: 168-179.
26. Tang X-L, Sato H, Tiwari S, Dawn B, Bi Q, Li Q, et al. Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions < 45 min. Am J Physiol Heart Circ Physiol 2006; 291: H2308-H2317.
27. Galagudza M, Kurapeev D, Minasian S, Valen G, Vaage J. Ischemic postconditioning: brief ischemia during reperfusion converts persistent ventricular fibrillation into regular rhythm. Eur J Cardiothorac Surg 2004; 25: 1006-1010.
28. Sasaki H, Shimizu M, Ogawa K, Okazaki F, Taniguchi M, Taniguchi I, et al. Brief ischemia-reperfusion performed after prolonged ischemia (ischemic postconditioning) can terminate reperfusion arrhythmias with no reduction of cardiac function in rats. Int Heart J 2007; 48: 205-213.
29. Jiang R, Reeves JG, Mykytenko J, Zatta JZ, Kin H, Jobe LJ, et al. Postconditioning reduces reperfusion injury by inhibiting the tissue factor - thrombin pathway in a closed-chest porcine model of ischemia -reperfusion [abstract]. Circulation 2005; 112(Suppl II): 309.
30. Skyschally A, Gres P, Van Caster P, Schulz R, Heusch G. Postconditioning reduces infarct size after ischemia/reperfusion in pigs. J Molec Cell Cardiol 2007; 42: S171-S189.
31. Zhao J-L, Yang Y-J, You S-J, Cui C-J, Gao R-L. Different effects of postconditioning on myocardial no-reflow in the normal and hypercholesterolemic mini-swines. Microvasc Res 2007; 73: 137-142.
32. Heusch G, Büchert A, Feldhaus S, Schulz R. No loss of cardioprotection by postconditioning in connexin 43-deficient mice. Basic Res Cardiol 2006; 101: 354-356.
33. Lim SY, Davidson SM, Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: The essential role of the mitochondrial permeability transition pore. Cardiovasc Res 2007; 75: 530-535.
34. Boengler K, Buechert A, Heinen Y, Hilfiker-Keiner D, Heusch G, Schulz R. Ischemic postconditioning's cardioprotection is lost in aged and STAT3-deficient mice [abstract]. J Mol Cell Cardiol 2007; 42: S182.
35. Kin H, Zatta AJ, Lofye MT, Amerson BS, Halkos ME, Kerendi F, et al. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res 2005; 67: 124-133.
36. 2A adenosine receptors attenuates the protective effects of myocardial postconditioning. Am J Physiol Heart Circ Physiol 2007; 293(4): H2523-H2529.
37. Kin H, Zhao Z-Q, Sun H-Y, Wang N-P, Corvera JS, Halkos ME, et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 2004; 62: 74-85.
38. Wang J, Gao Q, Shen J, Ye TM, Xia Q. [Kappa-opioid receptor mediates the cardioprotective effect of ischemic postconditioning.] Zhejiang Da Xue Xue Bao Yi Xue Ban 2007; 36: 41-47.
39. Manintveld OC, Te Lintel Hekkert M, Van den Bos EJ, Suurenbroek GM, Dekkers DH, Verdouw PD, et al. Cardiac effects of postconditioning depend critically on the duration of index ischemia. Am J Physiol Heart Circ Physiol 2007; 292: H1551-H1560.
40. Tillack D, Reubner C, Strasser RH, Weinbrenner C. Postconditioning the in vivo rat heart reduces myocardial injury through a PI3K- and mTOR-dependent pathway which involves the activation of GSK3beta [abstract]. J Mol Cell Cardiol 2006; 40: 971.
41. Bopassa J-N, Ferrera R, Gateau-Roesch O, Couture-Lepetit E, Ovize M. PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc Res 2006; 69: 178-185.
42. Lauzier B, Sicard P, Bouchot O, Delemasure S, Menetrier F, Moreau D, et al. After four hours of cold ischemia and cardioplegic protocol, the heart can still be rescued with postconditioning. Transplantation 2007; 84(11): 1474-1482.
43. Dow J, Kloner RA. Postconditioning does not reduce myocardial infarct size in an in vivo regional ischemia rodent model. J Cardiovasc Pharmacol Ther 2007; 12(2): 153-163.
44. Kloner RA, Dow J, Bhandari A. Postconditioning markedly attenuates ventricular arrhythmias after ischemia-reperfusion. J Cardiovasc Pharmacol Ther 2006; 11(1): 55-63.
45. Crisostomo PR, Wang M, Wairiuko GM, Terrell AM, Meldrum DR. Postconditioning in females depends on injury severity. J Surg Res 2006; 134: 342-347.
46. Kaljusto ML, Mori T, Mohammad Husain Rizvi S, Galagudza M, Frantzen ML, Valen G, Vaage J. Postconditioning in rats and mice. Scand Cardiovasc J 2006; 40(6): 334-341.
47. Van Vuuren D, Genis A, Genade A, Lochner A. Postconditioning the isolated working rat heart. Cardiovasc Drugs Ther 2008. doi 10. 1007/s10557-008-6119-6.
48. Schwartz LM, Lagranha CJ. Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs. Am J Physiol Heart Circ Physiol 2006; 290: H1011-H1018.
49. Iliodromitis EK, Georgiadis M, Cohen MV, Downey JM, Bofilis E, Kremastinos DT. Protection from postconditioning depends on the number of short ischemic insults in anesthetized pigs. Basic Res Cardiol 2006; 101: 502-507.
50. Vinten-Johansen J, Zhao Z-Q, Jiang R, Zatta AJ, Dobson GP. Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury. J Appl Physiol 2007; 103: 1441-1448.
51. 2+ overload. Am J Physiol Heart Circ Physiol 2005; 288: H1900-H1908.
52. Sun H-Y, Wang N-P, Halkos M, Kerendi F, Kin H, Guyton RA, et al. Postconditioning attenuates cardiomyocyte apoptosis via inhibition of JNK and p38 mitogen-activated protein kinase signaling pathways. Apoptosis 2006; 11: 1583-1593.
53. ATP channels in mitochondria [abstract]. Circulation 2006; 114(8): suppl II-261.
54. Wang H-C, Zhang H-F, Guo W-Y, Su H, Zhang K-R, Li Q-X, et al. Hypoxic postconditioning enhances the survival and inhibits apoptosis of cardiomyocytes following reoxygenation: role of peroxynitrite formation. Apoptosis 2006; 11: 1453-1460.
55. 1 adenosine receptors in rabbit heart. Circulation 1991; 84: 350-356.
56. Goto M, Liu Y, Yang X-M, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995; 77: 611-621.
57. Tritto I, D'Andrea D, Eramo N, Scognamiglio A, De Simone C, Violante A, et al. Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res 1997; 80: 743-748.
58. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Molec Cell Cardiol 1997; 29: 207-216.
59. Fryer RM, Pratt PF, Hsu AK, Gross GJ. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther 2001; 296(2): 642-649.
60. Tong H, Chen W, Steenbergen C, Murphy E. Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res 2000; 87: 309-315.
61. Uchiyama T, Engelman RM, Maulik N, Das DK. Role of Akt signaling in mitochondrial survival pathway triggered by hypoxic preconditioning. Circulation 2004; 109: 3042-3049.
62. Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol 2005; 288: H971-H976.
63. Hausenloy DJ, Mocanu MM, Yellon DM. Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning. Cardiovasc Res 2004; 63: 305-312.
64. Juhaszova M, Zorov DB, Kim S-H, Pepe S, Fu Q, Fishbein KW, et al. Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004; 113(11): 1535-1549.
65. Hausenloy DJ, Wynne A, Duchen M, Yellon D. transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation 2004; 109: 1714-1717.
66. Halestrap AP, Clarke SJ, Khaliulin I. The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta 2007; 1767: 1007-1931.
67. Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 2002; 55: 534-543.
68. Javadov SA, Clarke S, Das M, Griffiths EJ, Lim KHH, Halestrap AP. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol 2003; 549: 513-524.
69. Zhao Z-Q, Vinten-Johansen J. Postconditioning: Reduction of reperfusion-induced injury. Cardiovasc Res 2006; 70: 200-211.
70. Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: United at reperfusion. Pharmacol Ther 2007; 116(2): 173-191.
71. 2+. J Biol Chem 1993; 268(2): 1011-1016.
72. ATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc Res 2007; 75: 168-177.
73. Kin H, Zatta AJ, Jiang R, Reeves JG, Mykytenko J, Sorescu G, et al. Activation of opioid receptors mediates the infarct size reduction by postconditioning [abstract]. J Molec Cell Cardiol 2005; 38: 827.
74. + channel and protein kinase C activation. Basic Res Cardiol 2006; 101: 180-189.
75. Tsutsumi YM, Yokoyama T, Horikawa Y, Roth DM, Patel HH. Reactive oxygen species trigger ischemic and pharmacological postconditioning: In vivo and in vitro characterization. Life Sci 2007; 81: 1223-1227.
76. ATP channels in mitochondria [abstract]. Circulation 2006; 114(8 Suppl II): 261.
77. Zhu M, Feng J, Lucchinetti E, Fischer G, Xu L, Pedrazzini T, et al. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway. Cardiovasc Res 2006; 72: 152-162.
78. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res 2004; 61: 448-460.
79. Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM. Postconditioning: A form of 'modified reperfusion' protects the myocardium by activating the phosphatidylinositol 3-kinase-akt pathway. Circ Res 2004; 95: 230-232.
80. Jang Y, Xi J, Wang H, Mueller RA, Norfleet EA, Xu Z. Postconditioning prevents reperfusion injury by activating δ-opioid receptors. Anesthesiology 2008; 108(2): 243-250.
81. Cohen MV, Yang X-M, Downey JM. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 2007; 115: 1895-1903.
82. Crompton M. Mitochondrial intermembrane junctional complexes and their role in cell death. J Physiol 2000; 529.1: 11-21.
83. Loukogeorgakis SP, Panagiotidou AT, Yellon DM, Deanfield JE, MacAllister RJ. The postconditioning protects against endothelial ischemia-reperfusion injury in human forearm. Circulation 2006; 113: 1015-1019.
84. Sivaraman V, Mudalagiri NR, Di Salvo C, Kolvekar S, Hayward M, Yap J, et al. Postconditioning protects human atrial muscle through the activation of the RISK pathway. Basic Res Cardiol 2007; 102: 453-459.
85. Laskey WK. Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter Cardiovasc Interv 2005; 65: 361-367.
86. Darling CE, Solari PB, Smith CS, Furman MI, Przyklenk K. 'Postconditioning' the human heart: Multiple balloon inflations during primary angioplasty may confer cardioprotection. Basic Res Cardiol 2007; 102(3): 274-278.
87. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, et al. Postconditioning the Human Heart. Circulation 2005; 112: 2143-2148.
88. Yang X-C, Liu Y, Wang L-F, Cui L, Wang T, Ge Y-G, et al. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention. J Invasive Cardiol 2007; 19: 424-430.
89. Ma X, Zhang X, Li C, Luo M. Effect of postconditioning on coronary blood flow velocity and endothelial function and LV recovery after myocardial infarction. J Interven Cardiol 2006; 19: 367-375.
90. Luo W, Li B, Chen R, Huang R, Lin G. Effect of ischemic postconditioning in adult valve replacement. Eur J Cardiothorac Surg 2008; 33(2): 203-208.
91. Yang X-M, Krieg T, Cui L, Downey JM, Cohen MV. NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. J Mol Cell Cardiol 2004; 36: 411-421.
92. Burley DS, Baxter GF. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart. Basic Res Cardiol 2007; 102: 529-541.
93. Jin Z-X, Zhou J-J, Xin M, Peng D-R, Wang X-M, Bi S-H, et al. Postconditioning the human heart with adenosine in heart valve replacement surgery. Ann Thorac Surg 2007; 83: 2066-2073.